| __timestamp | GSK plc | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 8246000000 | 22570000 |
| Thursday, January 1, 2015 | 9232000000 | 24378000 |
| Friday, January 1, 2016 | 9366000000 | 26621000 |
| Sunday, January 1, 2017 | 9672000000 | 28653000 |
| Monday, January 1, 2018 | 9915000000 | 37734000 |
| Tuesday, January 1, 2019 | 11402000000 | 41884000 |
| Wednesday, January 1, 2020 | 11456000000 | 64435000 |
| Friday, January 1, 2021 | 10975000000 | 57483000 |
| Saturday, January 1, 2022 | 8372000000 | 70062000 |
| Sunday, January 1, 2023 | 9385000000 | 52790000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of GSK plc and Ligand Pharmaceuticals Incorporated from 2014 to 2023. GSK, a global healthcare giant, consistently reported SG&A expenses that were exponentially higher than those of Ligand, a smaller biopharmaceutical company. In 2020, GSK's expenses peaked at approximately 11.5 billion, while Ligand's expenses reached their highest in 2022 at around 70 million. Despite the vast difference in scale, Ligand's expenses grew by over 200% during this period, reflecting its strategic investments in growth. Meanwhile, GSK's expenses showed a more modest increase of about 14%, indicating a stable yet expansive operational strategy. This financial narrative highlights the contrasting paths of two distinct players in the pharmaceutical landscape.
Operational Costs Compared: SG&A Analysis of GSK plc and Teva Pharmaceutical Industries Limited
GSK plc and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: GSK plc vs Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: GSK plc vs Exelixis, Inc. Trends and Insights
GSK plc vs Axsome Therapeutics, Inc.: SG&A Expense Trends
GSK plc or Corcept Therapeutics Incorporated: Who Manages SG&A Costs Better?
Insmed Incorporated and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Perrigo Company plc and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of ImmunityBio, Inc. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Celldex Therapeutics, Inc.